Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Clinical Applications of Sentinel Lymph Node Biopsy: From Melanoma to Breast Cancer

Kinam Zhiang

Sentinel lymph node biopsy (SLNB) has evolved as a crucial technique in surgical oncology, revolutionizing cancer staging and therapeutic decision-making across various malignancies. This comprehensive review explores the clinical applications of SLNB, spanning the spectrum from melanoma to breast cancer. By focusing on these distinct tumor types, we aim to highlight the versatility and impact of SLNB in diverse clinical scenarios. In melanoma, SLNB has emerged as a gold standard for nodal staging, allowing for precise identification of sentinel lymph nodes and facilitating early detection of metastatic disease. We discuss the evolving role of SLNB in melanoma management, addressing its diagnostic accuracy, prognostic significance, and influence on treatment strategies. Breast cancer represents another area where SLNB has made significant inroads. Its utilization has enabled clinicians to tailor surgical approaches and adjuvant therapies, minimizing unnecessary axillary dissections and their associated morbidity. We examine the current guidelines and controversies surrounding SLNB in breast cancer, shedding light on its integration into multidisciplinary care.